• Hormone Receptor-Positive Breast Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hormonal Therapy for Hormone Receptor-Positive Breast Cancer

  • Jun 20 2024
  • Durée: 2 h et 2 min
  • Podcast

Page de couverture de Hormone Receptor-Positive Breast Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hormonal Therapy for Hormone Receptor-Positive Breast Cancer

Hormone Receptor-Positive Breast Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hormonal Therapy for Hormone Receptor-Positive Breast Cancer

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • Featuring perspectives from Dr Harold J Burstein, Ms Kelly Fischer, Dr Komal Jhaveri and Ms Melissa Rikal, including the following topics:

    • Introduction (0:00)
    • The Utility of Genomic Assays in Treatment Decision-Making for HR-Positive, HER2-Negative Localized Breast Cancer (10:21)
    • The Role of CDK4/6 Inhibitors in Therapy for HR-Positive Breast Cancer (37:18)
    • Oral Selective Estrogen Receptor Degraders in the Management of HR-Positive Metastatic Breast Cancer (mBC) (1:04:27)
    • Alpelisib and Capivasertib in Treatment for HR-Positive mBC (1:28:40)

    NCPD information and select publications
    Voir plus Voir moins
activate_primeday_promo_in_buybox_DT
Troubles et maladies Hygiene & Healthy Living Science
Voir plus Voir moins

Ce que les auditeurs disent de Hormone Receptor-Positive Breast Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hormonal Therapy for Hormone Receptor-Positive Breast Cancer

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.